Table 2.
Sample Characteristics
| CHR | Control | |
|---|---|---|
| N | 740 | 280 |
| Age, years (mean ± SD)** | 18.5 (± 4.26) | 19.7 (± 4.67) |
| Sex, n (%)* | ||
| Males | 424 (57.3%) | 141 (50.4%) |
| Females | 316 (42.7%) | 139 (49.6%) |
| Race, n (%) | ||
| White | 426 (57.6%) | 152 (54.3%) |
| Black | 111 (15%) | 49 (17.5%) |
| Interracial | 94 (12.7%) | 29 (10.4%) |
| Central/South American | 32 (4.3%) | 13 (4.6%) |
| East Asian | 19 (2.6%) | 15 (5.4%) |
| South Asian | 20 (2.7%) | 8 (2.9%) |
| Southeast Asian | 15 (2.0%) | 7 (2.5%) |
| First Nations | 13 (1.8%) | 4 (1.4%) |
| West/Central Asia and Middle East | 6 (0.8%) | 2 (0.7%) |
| Native Hawaiian or Pacific Islander | 3 (0.4%) | 1 (0.4%) |
| Ethnicity (Hispanic/Lantinx), n (%) | 136 (18.4%) | 50 (17.9%) |
| Attenuated Psychotic Symptoms, mean (SD)** | 11.86 (3.832) | 1.07 (1.67) |
| Negative Symptoms, mean (SD) ** | 11.89 (6.067) | 1.46 (2.23) |
| Sleep Disturbance, mean (SD) ** | 2.31 (1.568) | 0.48 (.904) |
Percentages add up to > 100% because one participant can score multiple items.
p <.05
p<.01